In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Since the start of 2020, Eli Lilly ... company, Genetic Leap. The partnership centers on developing new drugs, particularly those targeting RNA, which attempt to treat diseases at their genetic ...

BMO Capital Markets increased their price target on shares ... Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the ...

Data from the two Phase III trials showed that efsitora induced HbA1C reductions similar to daily insulin in both type 1 and ...

The original concerns of the US regulatory agency over the manufacturing of Eli Lilly’s Ebglyss seem to have been resolved, ...

Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping ... compounds, the company said in the release. Arctoris said they expect their expanded ...

They compared their progress with people who require daily insulin injections. Eli Lilly officials said their ... “This long-acting formulation could help address adherence issues associated ...

Eli Lilly and Company has revealed positive topline results from the Phase III trials of efsitora alfa to treat adults with ...